Next Article in Journal
Investigation on Indoor Air Pollution and Childhood Allergies in Households in Six Chinese Cities by Subjective Survey and Field Measurements
Next Article in Special Issue
Determinants of FDI Localization in China: A County-Level Analysis for the Pharmaceutical Industry
Previous Article in Journal
Job Stress and Presenteeism among Chinese Healthcare Workers: The Mediating Effects of Affective Commitment
Previous Article in Special Issue
Transnational Research Networks in Chinese Scientific Production. An Investigation on Health-Industry Related Sectors
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessFeature PaperArticle
Int. J. Environ. Res. Public Health 2017, 14(9), 976; doi:10.3390/ijerph14090976

Pharmaceutical Industry in Vietnam: Sluggish Sector in a Growing Market

Department of Economics and Management, University of Ferrara, Via Voltapaletto 11, 44121 Ferrara FE, Italy
Vietnam Academy of Social Sciences, 1 Liễu Giai, Ba Đình, Hà Nội 119-405, Vietnam
Author to whom correspondence should be addressed.
Received: 27 July 2017 / Revised: 16 August 2017 / Accepted: 24 August 2017 / Published: 29 August 2017
View Full-Text   |   Download PDF [1549 KB, uploaded 29 August 2017]   |  


Vietnam is a fast growing economy in the Asian region with a significantly high population (over 92 million in 2015). Although still expanding (about 1.1% on average during 2000–2015), the Vietnamese population is considered to be entering the ageing stage at a very high rate. The rapid expansion of the middle-income urban class and the ageing people ratio have dramatically pushed up the demand for healthcare goods, particularly in terms of pharmaceutical products. Since the early 1990s the government has addressed the necessities of rising demand for healthcare products by formulating a series of policies aimed at promoting the development of the pharmaceutical industry. However, the implementation of such policies does not seem to have been completely efficient given that the country still needs to import up to 90% of its pharmaceutical consumption. This paper aims to explore the development of the pharmaceutical industry during the years 1990–2015 and to identify a series of weaknesses in the government promotion of the industry. Future developments will also be discussed on how the Vietnamese pharmaceutical industry could increase its participation in the regional supply chain, which is currently being dominated by big players like India and China. View Full-Text
Keywords: pharmaceutical industry; Vietnam; emerging markets pharmaceutical industry; Vietnam; emerging markets

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Angelino, A.; Khanh, D.T.; An Ha, N.; Pham, T. Pharmaceutical Industry in Vietnam: Sluggish Sector in a Growing Market. Int. J. Environ. Res. Public Health 2017, 14, 976.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top